Vitamin K (Phytonadione,
Mephyton, AquaMephyton)
Category:
Description:
Indications:
-
Vitamin
K deficiency
-
Coagulation
disorders (blood clotting factors)
-
Anticoagulant-induced
prothrombin deficiency
-
Prophylaxis
and treatment of hemorrhagic disease in newborn
-
Warfarin
overdose antidote
Contraindications:
Precautions:
-
Pregnancy
category C
-
Vitamin
K deficiency is
-
Patients
may develop hypervitaminosis K with excessive intravenous dosages. Symptoms of hypervitaminosis are “flushing sensations”,
taste changes and rarely, dizziness sweating and rapid and weak pulse.
-
Vitamin
K will NOT reverse the anticoagulant effects of heparin.
-
Reversal
of coumarin class (warfarin) anticoagulation takes from 1-2 hours.
-
Vitamin
K is excreted into breast milk.
Adverse
Reactions (Side Effects):
Relatively
non-toxic in therapeutic doses
Hyperbilirubinemia
in newborns, occurring at doses greater than recommended.
|
Dosage:
-
Dietary
sources: pork, liver, green leafy vegetables (spinach, broccoli), GI
flora can produce from diet
-
Administered
in oral soft gelatin capsules or injection
-
Dietary
supplementation (RDA: recommended daily allowance):
-
Anticoagulant-induced
prothrombin deficiency: 2.5-10mg per day (up to 25mg initially)
-
Hemorrhagic
disease in newborn:
-
prophylaxis:
single IM dose 0.5-1mg within 1 hour of birth, may repeat in 2-3
weeks. Mother may
receive 1-5mg 12-24 hours before delivery. Oral doses of 2mg are adequate.
-
treatment:
1mg SQ or IM, in conjunction with proper laboratory testing of PT.
-
Hypoprothrombinemia
in adults:
|
Home
· Military Medicine
· Sick Call · Basic Exams
· Medical Procedures
· Lab and X-ray · The Pharmacy
· The Library · Equipment
· Patient Transport
· Medical Force
Protection · Operational Safety · Operational
Settings · Special
Operations · Humanitarian
Missions · Instructions/Orders · Other Agencies · Video Gallery
· Forms · Web Links · Acknowledgements
· Help · Feedback Approved for public release;
Distribution is unlimited. The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.
Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.
Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations
Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
*This web version is provided by The Brookside Associates, LLC. It contains
original contents from the official US Navy NAVMED P-5139, but has been
reformatted for web access and includes advertising and links that were not
present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the
Department of the Navy or the Department of Defense. The presence of any
advertising on these pages does not constitute an endorsement of that product or
service by either the US Department of Defense or the Brookside Associates. The
Brookside Associates is a private organization, not affiliated with the United
States Department of Defense.
© 2015, Brookside Associates, LLC. All rights reserved
Other Brookside Products
|
|